FDA Investigator: Mary E. Wilkerson-Brinsko

- Mary E. Wilkerson-Brinsko first started conducting FDA inspections in 2002, with the last inspection in 2013. Over that time, Mary E. Wilkerson-Brinsko has conducted 160 inspections at 108 companies across 122 sites.

Get Mary Wilkerson-Brinsko's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Bruce A. Buckingham, M.D., Stanford | 2013

Out-of-stock
Mary E. Wilkerson-Brinsko
Medical Devices & Rad Health Form 483

FDA 483 Children's Hospital and Research Center Oakland, Oakland | 2013

Out-of-stock
Mary E. Wilkerson-Brinsko
Biologic Form 483

FDA 483 UC Davis Medical Center Blood Bank, Sacramento | 2012

Out-of-stock
Mary E. Wilkerson-Brinsko
Biologic Form 483

FDA 483 Christopher S. Hall, M.D., San Francisco | 2012

Out-of-stock
Mary E. Wilkerson-Brinsko
Biologic Form 483

FDA 483 Central Coast Multispecialty Medical Group, Inc., Monterey | 2012

Out-of-stock
Mary E. Wilkerson-Brinsko
Biologic Form 483

FDA 483 Blood Centers Of The Pacific, Fairfield | 2012

Out-of-stock
Mary E. Wilkerson-Brinsko
Biologic Form 483

FDA 483 St. Theresa's General Hospital, Hyderabad | 2012

Out-of-stock
Mary E. Wilkerson-Brinsko
Human Drug Form 483

FDA 483 SanFrancisco Fertility Center, A Medical Corporation, San Francisco | 2012

Out-of-stock
Mary E. Wilkerson-Brinsko
Biologic Form 483

FDA 483 John Muir Medical Center IRB #1, Concord | 2012

Out-of-stock
Mary E. Wilkerson-Brinsko
Human Drug Form 483

FDA 483 Department of the Air Force, Nellis Afb | 2012

Out-of-stock
Mary E. Wilkerson-Brinsko
Biologic Form 483

FDA 483 Biomat USA, Inc., Las Vegas | 2012

Out-of-stock
Mary E. Wilkerson-Brinsko
Biologic Form 483